200 related articles for article (PubMed ID: 26719710)
21. MicroRNA HSA-miR-125a-5p induces apoptosis by activating p53 in lung cancer cells.
Jiang L; Huang Q; Chang J; Wang E; Qiu X
Exp Lung Res; 2011 Sep; 37(7):387-98. PubMed ID: 21777146
[TBL] [Abstract][Full Text] [Related]
22. miR-125a-5p post-transcriptionally suppresses GALNT7 to inhibit proliferation and invasion in cervical cancer cells via the EGFR/PI3K/AKT pathway.
Cao Q; Wang N; Ren L; Tian J; Yang S; Cheng H
Cancer Cell Int; 2020; 20():117. PubMed ID: 32308562
[TBL] [Abstract][Full Text] [Related]
23. LncSNHG14 promotes ovarian cancer by targeting microRNA-125a-5p.
Zhao YL; Huang YM
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3235-3242. PubMed ID: 31081075
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-125a-5p induces mouse granulosa cell apoptosis by targeting signal transducer and activator of transcription 3.
Wang C; Li D; Zhang S; Xing Y; Gao Y; Wu J
Menopause; 2016 Jan; 23(1):100-7. PubMed ID: 26154273
[TBL] [Abstract][Full Text] [Related]
25. MiR-125a-5p Alleviates Dysfunction and Inflammation of Pentylenetetrazol- induced Epilepsy Through Targeting Calmodulin-dependent Protein Kinase IV (CAMK4).
Liu Q; Wang L; Yan G; Zhang W; Huan Z; Li J
Curr Neurovasc Res; 2019; 16(4):365-372. PubMed ID: 31490757
[TBL] [Abstract][Full Text] [Related]
26. Astemizole promotes the anti-tumor effect of vitamin D through inhibiting miR-125a-5p-meidated regulation of VDR in HCC.
Xu J; Wang Y; Zhang Y; Dang S; He S
Biomed Pharmacother; 2018 Nov; 107():1682-1691. PubMed ID: 30257386
[TBL] [Abstract][Full Text] [Related]
27. miR-125a-5p suppresses colorectal cancer progression by targeting VEGFA.
Yang X; Qiu J; Kang H; Wang Y; Qian J
Cancer Manag Res; 2018; 10():5839-5853. PubMed ID: 30510452
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-195-5p, a new regulator of Fra-1, suppresses the migration and invasion of prostate cancer cells.
Wu J; Ji A; Wang X; Zhu Y; Yu Y; Lin Y; Liu Y; Li S; Liang Z; Xu X; Zheng X; Xie L
J Transl Med; 2015 Sep; 13():289. PubMed ID: 26337460
[TBL] [Abstract][Full Text] [Related]
29. LAMC2 regulated by microRNA-125a-5p accelerates the progression of ovarian cancer via activating p38 MAPK signalling.
Zhang D; Guo H; Feng W; Qiu H
Life Sci; 2019 Sep; 232():116648. PubMed ID: 31301414
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of hsa-miR-125a-5p enhances proliferation, migration and invasion of head and neck squamous cell carcinoma cell lines by upregulating C-C chemokine receptor type 7.
Jin S; Liu MD; Wu H; Pang P; Wang S; Li ZN; Sun CF; Liu FY
Oncol Lett; 2018 Jun; 15(6):9703-9710. PubMed ID: 29928346
[TBL] [Abstract][Full Text] [Related]
31. Differentially expressed miR-20, miR-21, miR-100, miR-125a and miR-146a as a potential biomarker for prostate cancer.
Damodaran M; Chinambedu Dandapani M; SimonDuraiRaj ; SandhyaSundaram ; VenkatRamanan S; Ramachandran I; Venkatesan V
Mol Biol Rep; 2021 Apr; 48(4):3349-3356. PubMed ID: 33948855
[TBL] [Abstract][Full Text] [Related]
32. miR-125a-5p impairs endothelial cell angiogenesis in aging mice via RTEF-1 downregulation.
Che P; Liu J; Shan Z; Wu R; Yao C; Cui J; Zhu X; Wang J; Burnett MS; Wang S; Wang J
Aging Cell; 2014 Oct; 13(5):926-34. PubMed ID: 25059272
[TBL] [Abstract][Full Text] [Related]
33. Long noncoding RNA BLACAT1 is overexpressed in hepatocellular carcinoma and its downregulation suppressed cancer cell development through endogenously competing against hsa-miR-485-5p.
Peng Y; Leng W; Duan S; Hong M
Biomed Pharmacother; 2019 Aug; 116():109027. PubMed ID: 31174090
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of microRNA-500 has anti-cancer effect through its conditional downstream target of TFPI in human prostate cancer.
Cai B; Chen W; Pan Y; Chen H; Zhang Y; Weng Z; Li Y
Prostate; 2017 Jul; 77(10):1057-1065. PubMed ID: 28631332
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-125a-5p is an independent prognostic factor in gastric cancer and inhibits the proliferation of human gastric cancer cells in combination with trastuzumab.
Nishida N; Mimori K; Fabbri M; Yokobori T; Sudo T; Tanaka F; Shibata K; Ishii H; Doki Y; Mori M
Clin Cancer Res; 2011 May; 17(9):2725-33. PubMed ID: 21220473
[TBL] [Abstract][Full Text] [Related]
36. LncRNA LOXL1-AS1/miR-let-7a-5p/EGFR-related pathway regulates the doxorubicin resistance of prostate cancer DU-145 cells.
Bai T; Liu Y; Li B
IUBMB Life; 2019 Oct; 71(10):1537-1551. PubMed ID: 31188543
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-493-5p promotes apoptosis and suppresses proliferation and invasion in liver cancer cells by targeting VAMP2.
Wang G; Fang X; Han M; Wang X; Huang Q
Int J Mol Med; 2018 Mar; 41(3):1740-1748. PubMed ID: 29328362
[TBL] [Abstract][Full Text] [Related]
38. miR-125a-5p inhibits cell proliferation and induces apoptosis in colon cancer via targeting BCL2, BCL2L12 and MCL1.
Tong Z; Liu N; Lin L; Guo X; Yang D; Zhang Q
Biomed Pharmacother; 2015 Oct; 75():129-36. PubMed ID: 26297542
[TBL] [Abstract][Full Text] [Related]
39. Curcumin exerts inhibitory effects on undifferentiated nasopharyngeal carcinoma by inhibiting the expression of miR-125a-5p.
Gao W; Chan JY; Wong TS
Clin Sci (Lond); 2014 Nov; 127(9):571-9. PubMed ID: 24896104
[TBL] [Abstract][Full Text] [Related]
40. Interfering histone deacetylase 4 inhibits the proliferation of vascular smooth muscle cells via regulating MEG3/miR-125a-5p/IRF1.
Zheng X; Wu Z; Xu K; Qiu Y; Su X; Zhang Z; Zhou M
Cell Adh Migr; 2019 Dec; 13(1):41-49. PubMed ID: 30156956
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
